Infectious Disease Alert – December 1, 2010
December 1, 2010
View Issues
-
Can We Diagnose Clostridium difficile Diarrhea with One Sample and One Test?
The authors tested samples sent to stanford hospital microbiology laboratory for diagnosis of C. difficile infection (CDI). -
Public Reporting of Central-line Infections Called into Question
Central line-associated infections, particularly bloodstream infections (BSI), remain a huge issue in our technological age. -
Rotavirus Vaccine and Intussusception: Rarely, at Least in Some Places
Post-marketing surveillance outside the United States of the two FDA-licensed rotavirus vaccines, RotaTeq (Merck, licensed in 2006) and Rotarix (GSK Biologicals, licensed in 2008), have identified a very low but increased risk (1 case/100,000 vaccinated infants) of intussusception following Rotarix vaccination. -
Clinical Features of Meningitis in Children
A structured search and analysis was conducted of all published articles describing historical and physical features of children with culture-confirmed bacterial meningitis. -
Monkeypox Epidemiology in the Post Smallpox-vaccination Era: Major Increases in the Democratic Republic of Congo
Monkeypox is an orthopoxvirus related to variola, which causes a clinically similar (although less severe) illness to smallpox. -
CXCR6 Chemokine Receptor and Long-term Non-progression to AIDS
The genomics of resistance to immunodeficiency virus (GRIV) Cohort was established in France in 1995 to generate a large database for genetic studies to identify host genes associated with rapid progression and long-term non-progression to AIDS. -
Intravenous Peramivir for Seasonal Influenza
In this study, 296 previously healthy eligible adults ages 20-64 with onset of influenza-like symptoms within the previous 48 hours and a positive rapid antigen test were enrolled in a double-blind, placebo-controlled trial conducted at Nagasaki University. -
Updates by Carol A. Kemper, MD, FACP
During the 2007-2008 and 2008-2009 influenza seasons, children ages 1-3 years, with influenza-like symptoms, were randomized to receive oseltamivir suspension vs. matching placebo for 5 days. -
Pharmacology Watch: Tiotropium for Uncontrolled Asthma
In this issue: Tiotropium for uncontrolled asthma, sibutramine pulled from market, incidence and mortality data from WHI, FDA Actions. -
Clinical Briefs in Primary Care supplement